Osteoactivin/HGFIN: Is it a tumor suppressor or mediator of metastasis in breast cancer?

Breast Cancer Research

Volumn 9, Issue 6, 2007, Pages

  Rose, April A N ^a   Siegel, Peter M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GPNMB PROTEIN, RAT; HEMATOPOIETIC GROWTH FACTOR INDUCIBLE NEUROKININ 1 TYPE, HUMAN; HEMATOPOIETIC GROWTH FACTOR INDUCIBLE NEUROKININ-1 TYPE, HUMAN; MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; BREAST TUMOR; CANCER INVASION; DISEASE MODEL; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IN SITU HYBRIDIZATION; METABOLISM; NOTE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 40349114559     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1791     Document Type: Letter

References (8)

1. Metz RL, Patel PS, Hameed M, Bryan M, Rameshwar P. Role of human HGFIN/nmb in breast cancer. Breast Cancer Res 2007, 9:R58. 10.1186/bcr1764, 17845721.
2. Rose AAN, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM. Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res 2007, 5:1001-1014. 10.1158/1541-7786.MCR-07-0119, 17951401.
3. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527. 10.1016/j.ccr.2006.10.008, 17157791.
4. Oncomine - Cancer Profiling Database. , http://www.oncomine.org
5. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan C-T, Bigner DD, Counter CM, Wang X-F. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003, 278:15951-15957. 10.1074/jbc.M211498200, 12590137.
6. Weterman MA, Ajubi N, van Dinter IM, Degen WH, van Muijen GN, Ruitter DJ, Bloemers HP. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 1995, 60:73-81. 10.1002/ijc.2910600111, 7814155.
7. Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL, et al. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin Cancer Res 2006, 12:1373-1382. 10.1158/1078-0432.CCR-05-2018, 16489096.
8. Pollack VA, Alvarez E, Tse KF, Torgov MY, Xie S, Shenoy SG, MacDougall JR, Arrol S, Zhong H, Gerwien RW, et al. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB. Cancer Chemother Pharmacol 2007, 60:423-435. 10.1007/s00280-007-0490-z, 17541593.